PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Nanobiotix: Positive Phase II / III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class NBTXR3 positive Phase II/III results during...
Continue Reading →
Europe

Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including overall survival

Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including o...
Continue Reading →
Europe

Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec Nanomedicine Drug Candidate in Ovarian Cancer

Maastricht, The Netherlands, October 25, 2018 / B3C newswire / -- Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for th...
Continue Reading →
Europe

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the Return of investigational drug products used in Clinical studi...
Continue Reading →
news

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

PCI continues expansion of its global clinical services network to California. Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourcing servic...
Continue Reading →
news

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even be...
Continue Reading →
news

Patients once thought incurable can benefit from high-dose radiation therapy

In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase ...
Continue Reading →
Asia Pacific

Yisheng receives approval for rabies vaccine clinical study

The PIKA rabies vaccine has completed Phase I and Phase II clinical studies in Singapore.   Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on...
Continue Reading →
Europe

NHS High Throughput Clinical Research Centres Could Bring Substantial Benefits for Patients

New whitepaper details the potential of High Throughput Centres to make U.K. country of choice for clinical research. Maidenhead, United Kingdom, 8 October 2018 – A n...
Continue Reading →
Asia Pacific

Fiasp is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart

Hyderabad, India, 12 October 2018 ­- For children and adolescents (1 to <18 years old) living with type 1 diabetes, Fiasp® (an ultra-fast acting formulation of ins...
Continue Reading →
Quotient